UNSPSC 51162626: Dextromethorphan

This classification denotes an opioid receptor agonist and opioid with the molecular formula C18H25NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 7355X3ROTS, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears US NIH Compound Identifier 3008. European Medicines Agency schedules Dextromethorphan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07051MIG.

UNSPSC 51162626 Dextromethorphan, a Commodity code, nominally names a specific pharmaceutical active ingredient, but recent state and local solicitations tagged under this code actually seek broader pharmaceutical procurement — naloxone (an opioid antagonist unrelated to dextromethorphan), safe drug deactivation systems, and multi-source generic pharmaceuticals and over-the-counter products supplied through authorized wholesalers. State and local health departments and cooperative purchasing alliances are the primary issuing bodies, seeking to stock community health facilities and member jurisdictions with pharmaceutical inventories through fixed-term contracts that typically run two years with optional renewals. Vendors must comply with current Good Manufacturing Practices, Drug Supply Chain Security Act requirements, FDA approvals, and substantial insurance coverage including commercial general liability of at least $2,000,000 to $5,000,000 per occurrence. E-Verify compliance, drug-free workplace certifications, and acceptance of performance penalties ranging from $200 to $1,500 per violation for reporting or onboarding failures are standard contractual obligations.

Activity under this code is concentrated in the Southeast and Upper Midwest. Seminole County, Florida issued an Invitation for Bid (IFB 60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline and quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the contract offers a two-year initial term with one-year renewal options on a fixed-fee basis. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and July 1, 2026 contract start date; this cooperative procurement spans Minnesota, Oregon, and other participating state and local government facilities, requiring vendors to work with three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and accept a 3 percent administrative fee plus price-weighted evaluation favoring competitive pricing at 75 percent.